On February 23, 2026, AVITA Medical (RCEL) disclosed one insider transaction. Executive O’Toole David D purchased 3,000 shares on February 19, 2026.
[Recent Insider Transactions]
Disclosure Date
Position
Name
Transaction Date
Buy/Sell
Quantity
Price per Share/USD
Total Amount/USD
February 23, 2026
Executive
O’Toole David D
February 19, 2026
Buy
3,000
4.15
12,500
August 29, 2025
Director
McNamara Robert
August 28, 2025
Buy
10,000
4.50
45,000
August 26, 2025
Executive
O’Toole David D
August 26, 2025
Buy
2,000
4.52
9,040.00
August 20, 2025
Director
McNamara Robert
August 19, 2025
Buy
10,000
5.00
50,000
August 12, 2025
Executive
O’Toole David D
August 12, 2025
Buy
2,000
4.81
9,620.00
June 2, 2025
Executive
O’Toole David D
May 30, 2025
Buy
1,923
4.78
9,186.17
March 10, 2025
Director
McNamara Robert
March 6, 2025
Buy
11,000
8.30
91,300
February 20, 2025
Executive
O’Toole David D
February 20, 2025
Buy
1,000
9.90
9,900.00
February 20, 2025
Director
McNamara Robert
February 20, 2025
Buy
10,000
10.09
100,900
February 19, 2025
Executive
O’Toole David D
February 19, 2025
Buy
1,000
10.25
10,250
[Company Profile]
AVITA Medical, Inc. was founded on December 21, 1992, in Australia. AVITA Medical is a leading acute wound care company dedicated to providing transformative solutions aimed at optimizing wound healing, accelerating patient recovery, and improving clinical and economic outcomes across the entire acute wound management process. Their technology, through a range of proprietary and complementary products, addresses key healing needs such as burns, trauma, and surgical repair, supporting wound bed preparation, final closure, and rehabilitation.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
US Stock Insider Trading | AVITA Medical disclosed one insider transaction on February 23
On February 23, 2026, AVITA Medical (RCEL) disclosed one insider transaction. Executive O’Toole David D purchased 3,000 shares on February 19, 2026.
[Recent Insider Transactions]
[Company Profile]
AVITA Medical, Inc. was founded on December 21, 1992, in Australia. AVITA Medical is a leading acute wound care company dedicated to providing transformative solutions aimed at optimizing wound healing, accelerating patient recovery, and improving clinical and economic outcomes across the entire acute wound management process. Their technology, through a range of proprietary and complementary products, addresses key healing needs such as burns, trauma, and surgical repair, supporting wound bed preparation, final closure, and rehabilitation.